FDA Expected to Allow Mix ‘n’ Match COVID-19 Vaccines
Agency will not recommend one vaccine over another but may say it is preferable to use same booster as the vaccine.
Allergy and Immunology Information Center
Flucelvax Quadrivalent Approval Expanded to Include Younger Patients
The expanded approval was based on data from a phase 3 study that compared Flucelvax Quadrivalent to a US-licensed comparator quadrivalent influenza vaccine.
What Should Parents Know About COVID-19 Vaccines?
With children back in school and COVID-19 cases persisting, parents may be concerned and seek information about the vaccine. What should they know about the COVID-19 vaccine for children?
NASEM: Building Parents’ Confidence in COVID-19 Vaccines
NASEM offers recommendations for communicating with parents of young children about COVID-19 vaccines.
AAP Updates Influenza Vaccination Guidance for Children
Routine annual influenza vaccination is recommended for all patients 6 months of age and older who have no medical contraindications.
Pfizer-BioNTech COVID-19 Vaccine Booster Dose Authorized for High-Risk Individuals
A single booster dose may be administered to individuals 65 years and older and those at high risk of severe disease or exposure to SARS-CoV-2.
Booster Dose of J&J COVID-19 Vaccine May Increase Immunity
New research indicates two doses of the vaccine boosts immunity from 74% to 94%
President Biden Pushes American Workers to Take COVID-19 Vaccine
President Joe Biden uses the full authority of his presidency to push Federal and health care workers to get vaccinated against COVID-19.
COVID-19 Vaccines Prevent Hospitalizations in High-Risk Populations
Estimates of vaccine effectiveness high for adults 85 years and older, those with chronic medical conditions, and for Hispanic and Black adults.
Israeli Study Shows Pfizer Booster Gives Seniors Big Rise in Immunity
A third dose of the Pfizer COVID-19 vaccine gives 4 times greater protection against COVID-19 infection, according to Israeli study.
FDA Grants First Full Approval to Pfizer-BioNTech COVID-19 Vaccine
Comirnaty is indicated for individuals 16 years of age and older, however the vaccine remains available to those aged 12 years and older under the EUA.
Decision on J&J COVID-19 Vaccine Booster Doses Could Take Weeks
Federal health officials are waiting on clinical trial results to determine whether a second shot of the J&J vaccine or a booster using another vaccine is best.
US Plans on COVID-19 Booster Shots as Soon as September
Americans will be able to start getting a booster of the mRNA COVID-19 vaccine starting September 20, 2021.
United States Sees Big Spike in COVID-19 Vaccinations
Daily number rose from 226,209 on July 5 to about 441,198 on Aug. 5
COVID-19 Vaccine Safe, Recommended for Pregnant Women, CDC Says
Latest recommendation comes after new data showed no raised risk for miscarriage in mothers-to-be during first 20 weeks
White House Outlines Effort to Vaccinate Young as Schools Start to Reopen
Push will include enlisting pediatricians to make COVID-19 vaccination part of back-to-school sports physicals.
Moderna COVID-19 Vaccine Maintains Efficacy 6 Months After Second Dose
The efficacy data was based on a final analysis of the phase 3 COVE study which evaluated the mRNA-1273 vaccine in more than 30,000 adults aged 18 years and older.
Pediatric Immunization Schedule: Best Available Evidence for 2021
Review of the 2021 Advisory Committee Immunization Practices updates to the pediatric immunization schedule during COVID-19.
New Data Show the Power of COVID-19 Vaccines
Data support what health experts have been saying for months: COVID-19 vaccines are highly effective at preventing serious illness and death
Janssen COVID-19 Vaccine Fact Sheet Updated With Guillain-Barre Syndrome Warning
The FDA has updated the fact sheet for the Janssen COVID-19 vaccine to include information related to an increased risk of Guillain-Barré syndrome.
- Loading...
Loading...
Want to read more?
Please login or register first to view this content.
Next post in Allergy and Immunology Information Center
Loading... 
Loading...